Physician

Ravi S Singh, M.D.

According to 2025 Medicare claims, Ravi Singh, M.D. (NPI: 1013119262) practices ophthalmology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is RETINA ASSOCIATES LLC (NPI: 1609818913; TIN: 481211774) and primary practice location at 66215-2857.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,193 traditional Medicare patients, billed 52,567 HCPCS/CPT codes, and received $4,308,988 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 906 prescription claims across 257 beneficiaries totaling $38,520 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 22 records totaling $656. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.3M2015 Medicare payment: $2,668,724 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,914,514 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,277,621 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,721,761 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,226,907 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,895,180 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,179,282 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,855,364 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,984,473 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,308,988 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,37114,364$2,668,724
20161,43716,687$2,914,514
20171,46317,362$3,277,621
20181,35116,618$3,721,761
20191,44018,299$4,226,907
20201,23816,932$3,895,180
20211,28317,638$4,179,282
20221,20315,509$3,855,364
20231,20525,976$3,984,473
20241,19352,567$4,308,988

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$29K$58K2015 Drug cost: $20,460 (USD; Tot_Drug_Cst)2016 Drug cost: $33,104 (USD; Tot_Drug_Cst)2017 Drug cost: $40,626 (USD; Tot_Drug_Cst)2018 Drug cost: $48,396 (USD; Tot_Drug_Cst)2019 Drug cost: $57,625 (USD; Tot_Drug_Cst)2020 Drug cost: $49,473 (USD; Tot_Drug_Cst)2021 Drug cost: $49,449 (USD; Tot_Drug_Cst)2022 Drug cost: $40,582 (USD; Tot_Drug_Cst)2023 Drug cost: $33,950 (USD; Tot_Drug_Cst)2024 Drug cost: $38,520 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015131395$20,460
2016175540$33,104
2017202712$40,626
2018182696$48,396
2019210861$57,625
2020185793$49,473
2021202831$49,449
2022186754$40,582
2023200784$33,950
2024257906$38,520

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2772,614$645
67028Injection of drug into eye4872,167$99
92014Established patient complete exam of visual system6721,041$87
92134Imaging of retina1,0483,226$31
92250Photography of the retina306345$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2278,745$7,675
CombiganBrimonidine Tartrate/Timolol18577$3,872
TravoprostTravoprost191,147$2,894
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol11555$2,445
Ketorolac TromethamineKetorolac Tromethamine1315,111$1,868

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$656Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ravi S. Singh, M.D.?

Tedicare shows public-source Medicare data for Ravi S. Singh, M.D. (NPI 1013119262), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ravi S. Singh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ravi S. Singh, M.D.?

Ravi S. Singh, M.D. is linked to RETINA ASSOCIATES LLC (billing NPI 1609818913) in the available physician profile data.

Does Ravi S. Singh, M.D. have Open Payments data?

Ravi S. Singh, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.